Total Valuation
Escalon Medical has a market cap or net worth of $1.43M. The enterprise value is -$3.34B.
Market Cap$1.43M
Enterprise Value-$3.34B
Share Statistics
Escalon Medical has 7,415,329 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,415,329
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Escalon Medical’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.46%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)5.46%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee308.88K
Profits Per Employee2.71K
Employee Count39
Asset Turnover2.41
Inventory Turnover<0.01
Valuation Ratios
The current PE Ratio of Escalon Medical is 1.8. Escalon Medical’s PEG ratio is -0.74.
PE Ratio1.8
PS Ratio0.20
PB Ratio1.25
Price to Fair Value1.25
Price to FCF6.31
Price to Operating Cash Flow<0.01
PEG Ratio-0.74
Income Statement
In the last 12 months, Escalon Medical had revenue of 12.05M and earned 105.53K in profits. Earnings per share was <0.01.
Revenue12.05M
Gross Profit5.51M
Operating Income133.22K
Pretax Income105.53K
Net Income105.53K
EBITDA166.04K
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was 280.57M and capital expenditures -3.88K, giving a free cash flow of 280.57M billion.
Operating Cash Flow280.57M
Free Cash Flow280.57M
Free Cash Flow per Share37.84
Dividends & Yields
Escalon Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.71
52-Week Price Change-28.52%
50-Day Moving Average0.19
200-Day Moving Average0.18
Relative Strength Index (RSI)48.30
Average Volume (3m)30.86K
Important Dates
Escalon Medical upcoming earnings date is May 14, 2018, After Close (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateMay 14, 2018
Ex-Dividend Date―
Financial Position
Escalon Medical as a current ratio of 1.72, with Debt / Equity ratio of 24.37%
Current Ratio1.72
Quick Ratio-796.07
Debt to Market Cap0.11
Net Debt to EBITDA-3.28K
Interest Coverage Ratio<0.01
Taxes
In the past 12 months, Escalon Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Escalon Medical EV to EBITDA ratio is -3.27K, with an EV/FCF ratio of -1.43K.
EV to Sales-45.07
EV to EBITDA-3.27K
EV to Free Cash Flow-1.43K
EV to Operating Cash Flow-1.43K
Balance Sheet
Escalon Medical has $3.34B in cash and marketable securities with $1.01M in debt, giving a net cash position of $3.34B billion.
Cash & Marketable Securities$3.34B
Total Debt$1.01M
Net Cash$3.34B
Net Cash Per Share$450.62
Tangible Book Value Per Share$0.25
Margins
Gross margin is 41.48%, with operating margin of 1.11%, and net profit margin of 0.88%.
Gross Margin41.48%
Operating Margin1.11%
Pretax Margin0.88%
Net Profit Margin0.88%
EBITDA Margin1.38%
EBIT Margin1.06%
Analyst Forecast
The average price target for Escalon Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-11.60%
EPS Growth Forecast136.81%